Search

everythinglearnresearchcommunity

for

Search:↓

The lotion CG428 did not show effectiveness in treating permanent hair loss in breast cancer survivors.

New inhibitors may reduce gut toxicity from cancer drugs.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Nivolumab can cause hair loss as a rare side effect.

Rezpegaldesleukin shows promise for treating severe alopecia areata.

Mohs micrographic surgery is effective for treating basal cell carcinoma on the eyelid, while radiotherapy has higher recurrence rates, and topical vitamin D3 may reduce and delay BCC formation in mice.

The treatment is safe and shows promise for metastatic breast cancer.

Biobran MGN-3 reduces chemotherapy side effects and improves quality of life for breast cancer patients.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

A girl with Evans' syndrome had her low platelet count successfully treated with zanubrutinib.

Vemurafenib can cause scalp issues but can be managed without changing the dose.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Preventive measures and effective management are crucial for reducing skin side effects in cancer treatment.

Dabrafenib can cause skin growths and sometimes low-grade skin cancer.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Rituximab may cause skin issues, but baricitinib can help improve them.

Cancer treatments often cause skin, nail, and hair problems.

Paclitaxel and nab-paclitaxel can be safe and effective for advanced gastric cancer patients on hemodialysis.

Deucravacitinib helped a man regrow hair and improve psoriasis.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

Sonidegib effectively treated advanced basal cell carcinoma with mild side effects.

Using a niacinamide cream can improve life quality for breast cancer patients during chemotherapy.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

Topical calcitriol may reduce hair loss from chemotherapy at higher doses.

Ustekinumab and vedolizumab can help some ulcerative colitis patients with hair regrowth, but results vary.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.